AGTR1 has been shown to be upregulated in ovarian cancer19; nevertheless, other studies have identified its reduced expression in lung adenocarcinoma, where overexpression of AGTR1 can suppress progression via the PI3K/AKT pathway.20 Although AGTR1 is confirmed to be downregulated in CC in this study, it is found to be correlated only with FIGO stage when analyzing its association with clinical parameters. The gene discussed is AKT1; the disease is lung adenocarcinoma.